Christian Berthou
Brest, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
MHC class II: a predictor of outcome in melanoma treated with immune checkpoint inhibitors.
Journal: Melanoma research
Published: February 13, 2025
Zn2+ triazamacrocyclic chelators with methylpyridine pendant arms for B-cell apoptosis: a structure-activity study.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: February 03, 2025
Review on radiomic analysis in 18F-fluorodeoxyglucose positron emission tomography for prediction of melanoma outcomes.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 02, 2023
HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker.
Journal: Frontiers in immunology
Published: August 30, 2023
Assessment of using ultrasonography to teach abdominal and cervical anatomy in French medical curricula.
Journal: Surgical and radiologic anatomy : SRA
Published: May 26, 2023
New Triazacycloalkane Derivatives as Cytotoxic Agents for CLL Treatment: From Proof of Concept to the Targeting Biomolecule.
Journal: Bioconjugate chemistry
Published: June 16, 2022
Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study.
Journal: Cancers
Published: June 06, 2022
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.
Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Published: February 08, 2022
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma.
Journal: Frontiers in nuclear medicine
Published: December 05, 2021
The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials.
Journal: Blood advances
Published: October 28, 2021
Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
Journal: Journal of leukocyte biology
Published: July 21, 2021
Last Updated: 09/26/2026